Open AccessHepatic Resection vs Minimally Invasive Radiofrequency Ablation for the Treatment of Colorectal Liver Metastases
Author(s) -
Yashodhan S. Khajanchee
Publication year - 2011
Publication title -
archives of surgery
Language(s) - English
Resource type - Journals
eISSN - 1538-3644
pISSN - 0004-0010
DOI - 10.1001/archsurg.2011.212
Subject(s) - medicine , radiofrequency ablation , quality of life (healthcare) , surgery , percutaneous , randomized controlled trial , life expectancy , colorectal cancer , ablation , cancer , population , nursing , environmental health
Current literature evaluating radiofrequency ablation (RFA) for treatment of colorectal liver metastases describes high-risk surgical candidates or patients with unresectable disease. This creates bias when comparing RFA and hepatic resection. A Markov analysis would define theoretical outcomes necessary for RFA to demonstrate equivalence to resection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom